Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 159

1.

Failure to detect an association between self-reported traumatic brain injury and Alzheimer's disease neuropathology and dementia.

Sugarman MA, McKee AC, Stein TD, Tripodis Y, Besser LM, Martin B, Palmisano JN, Steinberg EG, O'Connor MK, Au R, McClean M, Killiany R, Mez J, Weiner MW, Kowall NW, Stern RA, Alosco ML.

Alzheimers Dement. 2019 Mar 6. pii: S1552-5260(19)30009-3. doi: 10.1016/j.jalz.2018.12.015. [Epub ahead of print]

PMID:
30852157
2.

Phase I Trial of Inducible Caspase 9 T Cells in Adult Stem Cell Transplant Demonstrates Massive Clonotypic Proliferative Potential and Long-term Persistence of Transgenic T Cells.

Zhang P, Raju J, Ullah MA, Au R, Varelias A, Gartlan KH, Olver SD, Samson LD, Sturgeon E, Zomerdijk N, Avery J, Gargett T, Brown MP, Coin LJ, Ganesamoorthy D, Hutchins C, Pratt GR, Kennedy GA, Morton AJ, Curley CI, Hill GR, Tey SK.

Clin Cancer Res. 2019 Mar 15;25(6):1749-1755. doi: 10.1158/1078-0432.CCR-18-3069. Epub 2019 Feb 14.

PMID:
30765390
3.

Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers.

Tao Q, Ang TFA, DeCarli C, Auerbach SH, Devine S, Stein TD, Zhang X, Massaro J, Au R, Qiu WQ.

JAMA Netw Open. 2018 Oct 5;1(6):e183597. doi: 10.1001/jamanetworkopen.2018.3597.

4.

Fusion of deep learning models of MRI scans, Mini-Mental State Examination, and logical memory test enhances diagnosis of mild cognitive impairment.

Qiu S, Chang GH, Panagia M, Gopal DM, Au R, Kolachalama VB.

Alzheimers Dement (Amst). 2018 Sep 28;10:737-749. doi: 10.1016/j.dadm.2018.08.013. eCollection 2018.

5.

Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study's Old-Old.

Wong CG, Thomas KR, Edmonds EC, Weigand AJ, Bangen KJ, Eppig JS, Jak AJ, Devine SA, Delano-Wood L, Libon DJ, Edland SD, Au R, Bondi MW.

Dement Geriatr Cogn Disord. 2018;46(5-6):253-265. doi: 10.1159/000493541. Epub 2018 Nov 2.

PMID:
30391953
6.

Lewy Body Pathology and Chronic Traumatic Encephalopathy Associated With Contact Sports.

Adams JW, Alvarez VE, Mez J, Huber BR, Tripodis Y, Xia W, Meng G, Kubilus CA, Cormier K, Kiernan PT, Daneshvar DH, Chua AS, Svirsky S, Nicks R, Abdolmohammadi B, Evers L, Solomon TM, Cherry JD, Aytan N, Mahar I, Devine S, Auerbach S, Alosco ML, Nowinski CJ, Kowall NW, Goldstein LE, Dwyer B, Katz DI, Cantu RC, Stern RA, Au R, McKee AC, Stein TD.

J Neuropathol Exp Neurol. 2018 Sep 1;77(9):757-768. doi: 10.1093/jnen/nly065.

7.

A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.

Alosco ML, Sugarman MA, Besser LM, Tripodis Y, Martin B, Palmisano JN, Kowall NW, Au R, Mez J, DeCarli C, Stein TD, McKee AC, Killiany RJ, Stern RA.

J Alzheimers Dis. 2018;63(4):1347-1360. doi: 10.3233/JAD-180017.

8.

Assessment of the Mid-Life Demographic and Lifestyle Risk Factors of Dementia Using Data from the Framingham Heart Study Offspring Cohort.

Li J, Ogrodnik M, Kolachalama VB, Lin H, Au R.

J Alzheimers Dis. 2018;63(3):1119-1127. doi: 10.3233/JAD-170917.

PMID:
29710704
9.

Word-list intrusion errors predict progression to mild cognitive impairment.

Thomas KR, Eppig J, Edmonds EC, Jacobs DM, Libon DJ, Au R, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative*.

Neuropsychology. 2018 Feb;32(2):235-245. doi: 10.1037/neu0000413.

10.

Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.

Tao Q, Zhu H, Chen X, Stern RA, Kowall N, Au R, Blusztajn JK, Qiu WQ; Alzheimer’s Disease Metabolomics Consortium.

J Alzheimers Dis. 2018;62(2):597-609. doi: 10.3233/JAD-170948.

11.

How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.

Au R, Piers RJ, Devine S.

Neuropsychology. 2017 Nov;31(8):846-861. doi: 10.1037/neu0000411.

12.

Assessing Working Memory in Mild Cognitive Impairment with Serial Order Recall.

Emrani S, Libon DJ, Lamar M, Price CC, Jefferson AL, Gifford KA, Hohman TJ, Nation DA, Delano-Wood L, Jak A, Bangen KJ, Bondi MW, Brickman AM, Manly J, Swenson R, Au R; Consortium for Clinical and Epidemiological Neuropsychological Data Analysis (CENDA).

J Alzheimers Dis. 2018;61(3):917-928. doi: 10.3233/JAD-170555.

13.

White matter signal abnormalities in former National Football League players.

Alosco ML, Koerte IK, Tripodis Y, Mariani M, Chua AS, Jarnagin J, Rahimpour Y, Puzo C, Healy RC, Martin B, Chaisson CE, Cantu RC, Au R, McClean M, McKee AC, Lin AP, Shenton ME, Killiany RJ, Stern RA.

Alzheimers Dement (Amst). 2017 Nov 6;10:56-65. doi: 10.1016/j.dadm.2017.10.003. eCollection 2018.

14.

Barriers to medication adherence and links to cardiovascular disease risk factor control: the Framingham Heart Study.

Hennein R, Hwang SJ, Au R, Levy D, Muntner P, Fox CS, Ma J.

Intern Med J. 2018 Apr;48(4):414-421. doi: 10.1111/imj.13687.

15.

Data Platform for the Research and Prevention of Alzheimer's Disease.

An N, Jin L, Yang J, Yin Y, Jiang S, Jing B, Au R.

Adv Exp Med Biol. 2017;1028:55-78. doi: 10.1007/978-981-10-6041-0_4. Review.

PMID:
29058216
16.

Age and Graphomotor Decision Making Assessed with the Digital Clock Drawing Test: The Framingham Heart Study.

Piers RJ, Devlin KN, Ning B, Liu Y, Wasserman B, Massaro JM, Lamar M, Price CC, Swenson R, Davis R, Penney DL, Au R, Libon DJ.

J Alzheimers Dis. 2017;60(4):1611-1620. doi: 10.3233/JAD-170444.

PMID:
29036819
17.

Baseline White Matter Hyperintensities and Hippocampal Volume are Associated With Conversion From Normal Cognition to Mild Cognitive Impairment in the Framingham Offspring Study.

Bangen KJ, Preis SR, Delano-Wood L, Wolf PA, Libon DJ, Bondi MW, Au R, DeCarli C, Brickman AM.

Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):50-56. doi: 10.1097/WAD.0000000000000215.

18.

CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer's disease.

Cherry JD, Stein TD, Tripodis Y, Alvarez VE, Huber BR, Au R, Kiernan PT, Daneshvar DH, Mez J, Solomon TM, Alosco ML, McKee AC.

PLoS One. 2017 Sep 26;12(9):e0185541. doi: 10.1371/journal.pone.0185541. eCollection 2017.

19.

Atrial fibrillation and cognitive decline in the Framingham Heart Study.

Nishtala A, Piers RJ, Himali JJ, Beiser AS, Davis-Plourde KL, Saczynski JS, McManus DD, Benjamin EJ, Au R.

Heart Rhythm. 2018 Feb;15(2):166-172. doi: 10.1016/j.hrthm.2017.09.036. Epub 2017 Sep 22.

20.

Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem.

Arnerić SP, Cedarbaum JM, Khozin S, Papapetropoulos S, Hill DL, Ropacki M, Rhodes J, Dacks PA, Hudson LD, Gordon MF, Kern VD, Romero K, Vradenburg G, Au R, Karlin DR, Facheris MF, Fitzer-Attas CJ, Vitolo OV, Wang J, Miller BM, Kaye JA.

Nat Rev Drug Discov. 2017 Oct;16(10):736. doi: 10.1038/nrd.2017.153. Epub 2017 Sep 22. No abstract available.

PMID:
28935908

Supplemental Content

Support Center